Ignite Creation Date:
2025-12-24 @ 11:34 PM
Ignite Modification Date:
2026-01-10 @ 10:58 PM
Study NCT ID:
NCT02592356
Status:
COMPLETED
Last Update Posted:
2024-03-05
First Post:
2015-10-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-11-16
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-03-01
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-27
First Submit QC Date:
None
Study First Post Date:
2015-10-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-04
Last Update Post Date:
2024-03-05
Last Update Post Date Type:
ACTUAL